Ann Marie Mullally, MD - Medicare Internal Medicine in Boston, MA

Ann Marie Mullally, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Boston, Massachusetts. She graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice Dana-farber Cancer Institute, Inc. and her current practice location is 44 Binney St, Dana Farber Cancer Institute, Boston, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (617) 355-9060.

Ann Marie Mullally is licensed to practice in Massachusetts (license number 226952) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1679563910.

Contact Information

Ann Marie Mullally, MD
44 Binney St, Dana Farber Cancer Institute,
Boston, MA 02115-6013
(617) 355-9060
Not Available



Physician's Profile

Full NameAnn Marie Mullally
GenderFemale
SpecialityInternal Medicine
Experience25 Years
Location44 Binney St, Boston, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Ann Marie Mullally graduated from medical school in 1999
  NPI Data:
  • NPI Number: 1679563910
  • Provider Enumeration Date: 10/27/2005
  • Last Update Date: 04/05/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 8123020104
  • Enrollment ID: I20070203000133

Medical Identifiers

Medical identifiers for Ann Marie Mullally such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1679563910NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 226952 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Brigham And Women's HospitalBoston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Dana-farber Cancer Institute, Inc.9133038904538

News Archive

Big challenges from antibiotic resistant bacteria

Antibiotic resistant bacteria are increasing and spreading at an alarming speed. The bacterial evolution is overwhelming our antibiotic defense. More and more bacteria are becoming resistant to antibiotics resulting in fatal consequences for millions of people. We need common action and responsibility for the development of new effective antibiotics and to stop antibiotic misuse.

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement and mobile care coordination solutions, proudly congratulates Meritage Accountable Care Organization for being named a winner in the 6th Annual Dorland Health Case In Point Platinum Awards Program.

Scientists create synthesized antibiotic capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.

Research opens door to validation studies in multiple tumor types of liquid biopsy

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Most people have already experienced a fungal infection (mycosis) of the outer layer of the skin, athlete's foot or ringworm. Whereas such infections may be cumbersome and often difficult to cure, usually they are not dangerous. However, in cases where a fungus causes a systemic infection, this is, it infects internal organs such as lungs or brain, the infection may turn into a life-threatening disease. Of course, only pathogenic fungi cause problems and the degree of virulence varies.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ann Marie Mullally allows following entities to bill medicare on her behalf.
Entity NameDana-farber Cancer Institute, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346433257
PECOS PAC ID: 9133038904
Enrollment ID: O20040223000142

News Archive

Big challenges from antibiotic resistant bacteria

Antibiotic resistant bacteria are increasing and spreading at an alarming speed. The bacterial evolution is overwhelming our antibiotic defense. More and more bacteria are becoming resistant to antibiotics resulting in fatal consequences for millions of people. We need common action and responsibility for the development of new effective antibiotics and to stop antibiotic misuse.

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement and mobile care coordination solutions, proudly congratulates Meritage Accountable Care Organization for being named a winner in the 6th Annual Dorland Health Case In Point Platinum Awards Program.

Scientists create synthesized antibiotic capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.

Research opens door to validation studies in multiple tumor types of liquid biopsy

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Most people have already experienced a fungal infection (mycosis) of the outer layer of the skin, athlete's foot or ringworm. Whereas such infections may be cumbersome and often difficult to cure, usually they are not dangerous. However, in cases where a fungus causes a systemic infection, this is, it infects internal organs such as lungs or brain, the infection may turn into a life-threatening disease. Of course, only pathogenic fungi cause problems and the degree of virulence varies.

Read more Medical News

› Verified 4 days ago

Entity NameDana-farber Cancer Institute, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851333686
PECOS PAC ID: 9133038904
Enrollment ID: O20040223000228

News Archive

Big challenges from antibiotic resistant bacteria

Antibiotic resistant bacteria are increasing and spreading at an alarming speed. The bacterial evolution is overwhelming our antibiotic defense. More and more bacteria are becoming resistant to antibiotics resulting in fatal consequences for millions of people. We need common action and responsibility for the development of new effective antibiotics and to stop antibiotic misuse.

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement and mobile care coordination solutions, proudly congratulates Meritage Accountable Care Organization for being named a winner in the 6th Annual Dorland Health Case In Point Platinum Awards Program.

Scientists create synthesized antibiotic capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.

Research opens door to validation studies in multiple tumor types of liquid biopsy

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Most people have already experienced a fungal infection (mycosis) of the outer layer of the skin, athlete's foot or ringworm. Whereas such infections may be cumbersome and often difficult to cure, usually they are not dangerous. However, in cases where a fungus causes a systemic infection, this is, it infects internal organs such as lungs or brain, the infection may turn into a life-threatening disease. Of course, only pathogenic fungi cause problems and the degree of virulence varies.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ann Marie Mullally is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ann Marie Mullally, MD
1 Blackfan Cir, Karp 5.210,
Boston, MA 02115-5713

Ph: (443) 621-2228
Ann Marie Mullally, MD
44 Binney St, Dana Farber Cancer Institute,
Boston, MA 02115-6013

Ph: (617) 355-9060

News Archive

Big challenges from antibiotic resistant bacteria

Antibiotic resistant bacteria are increasing and spreading at an alarming speed. The bacterial evolution is overwhelming our antibiotic defense. More and more bacteria are becoming resistant to antibiotics resulting in fatal consequences for millions of people. We need common action and responsibility for the development of new effective antibiotics and to stop antibiotic misuse.

Meritage ACO named winner of Dorland Health Case In Point Platinum Award

Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement and mobile care coordination solutions, proudly congratulates Meritage Accountable Care Organization for being named a winner in the 6th Annual Dorland Health Case In Point Platinum Awards Program.

Scientists create synthesized antibiotic capable of treating superbugs

A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.

Research opens door to validation studies in multiple tumor types of liquid biopsy

Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis with a liquid biopsy, researchers at The University of Texas MD Anderson Cancer Center report online at the Annals of Oncology.

Jagaricin and antifungal drugs: an interview with Prof Christian Hertweck

Most people have already experienced a fungal infection (mycosis) of the outer layer of the skin, athlete's foot or ringworm. Whereas such infections may be cumbersome and often difficult to cure, usually they are not dangerous. However, in cases where a fungus causes a systemic infection, this is, it infects internal organs such as lungs or brain, the infection may turn into a life-threatening disease. Of course, only pathogenic fungi cause problems and the degree of virulence varies.

Read more News

› Verified 4 days ago


Internal Medicine Doctors in Boston, MA

Kaitlyn My-tu Lam, MBBS
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114
Phone: 617-724-7738    
Kui Toh Gerard Leong, M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114
Phone: 617-726-8862    
Ruma Rajbhandari,
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 75 Francis St, Boston, MA 02115
Phone: 617-525-6841    
Alaka Ray, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114
Phone: 617-726-2066    
Meghan E Sise, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114
Phone: 617-726-2862    
Aaron Dickstein, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 800 Washington St, Box 233, Boston, MA 02111
Phone: 617-636-5883    Fax: 617-636-9292
Dr. Felicia Elizabeth Patch, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118
Phone: 617-414-4376    Fax: 617-414-4676

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.